Sanotize is recruiting for a COVID trial in the province of Quebec.   

Dr. Ferid Murad

MD, PhD

Dr. Murad was a co-recipient of the 1998 Nobel Prize in Physiology or Medicine for the discovery that nitric oxide acts as a signalling molecule in the cardiovascular system. Dr. Murad along with Robert F. Furchgott, PhD,  and Louis J. Ignarro  PhD, identified an entirely new mechanism that explains how blood vessels in the body relax and widen. 

Dr. Murad was Chief of Medicine at the Palo Alto VA Medical Center (1981–1986), Associate Chairman, Dept. of Medicine, Stanford University (1984–1986), and Acting Chairman, Dept. of Medicine and Acting Division Chief, Division of Respiratory Medicine from 1986-1988.

Dr. Mike Abrams

PhD, Pharmaceutical Development

Over 35 years of experience in drug discovery and development. Dr. Abrams was the founding CEO of AnorMed and led the company for ten years. He is a co-recipient of the 2009 Georg Charles de Hevesy Nuclear Pioneer Award from the Society of Nuclear Medicine for his work in the discovery of the heart imaging agent Cardiolite.

Rose Wang

Investment

Ms. Wang is a Co-founder at M.Y. Capital Management Corp. and Co-founder and Principal at L.W. Property Advisors Ltd. She has nearly 20 years of experience in medium to large scaled commercial real estate development and valuations across the province, and is the youngest person to be awarded the Accredited Appraiser Canadian Institute designation (AACI) nationally. On the corporate side, she is highly experienced with strategic planning and business development.

Udi Daon

Corporate Governance

Mr. Daon is an award-winning serial innovator and entrepreneur with 20 years experience in the invention and commercialization of med-tech products.  He holds more than 70 patents in prosecution worldwide. He led and advised teams and companies and headed the commercial launch of more than 10 products.  Mr. Daon has multi-million dollar licensing and sales cycles experience.

logged in